+ All Categories
Home > Documents > THORACIC AORTIC PATHOLOGY CHALLENGES AND SOLUTIONS Thomas C. Naslund, M.D. Vanderbilt University...

THORACIC AORTIC PATHOLOGY CHALLENGES AND SOLUTIONS Thomas C. Naslund, M.D. Vanderbilt University...

Date post: 15-Jan-2016
Category:
Upload: prosper-gibson
View: 216 times
Download: 0 times
Share this document with a friend
Popular Tags:
35
THORACIC AORTIC PATHOLOGY CHALLENGES AND SOLUTIONS Thomas C. Naslund, M.D. Vanderbilt University Medical Center
Transcript
Page 1: THORACIC AORTIC PATHOLOGY CHALLENGES AND SOLUTIONS Thomas C. Naslund, M.D. Vanderbilt University Medical Center.

THORACIC AORTIC PATHOLOGY

CHALLENGES AND SOLUTIONS

Thomas C. Naslund, M.D.Vanderbilt University Medical Center

Page 2: THORACIC AORTIC PATHOLOGY CHALLENGES AND SOLUTIONS Thomas C. Naslund, M.D. Vanderbilt University Medical Center.

CONFLICT OF INTEREST

WL Gore Investigator, Speaker, Consultant

Boston Scientific Consultant

LeMaitre VascularScientific Advisory Board

Page 3: THORACIC AORTIC PATHOLOGY CHALLENGES AND SOLUTIONS Thomas C. Naslund, M.D. Vanderbilt University Medical Center.

OFF LABEL USE

• WL Gore TAG

• Cook Zenith

• WL Gore Excluder

Page 4: THORACIC AORTIC PATHOLOGY CHALLENGES AND SOLUTIONS Thomas C. Naslund, M.D. Vanderbilt University Medical Center.

FREQUENTLY SEEN PATHOLOGY

• Aneurysm

-fusiform *

-saccular (concern for infection)

• Aortic Dissection – Type A* and B

• Traumatic transection

• Penetrating ulcer

• Intramural hematoma

*labeled use for TAG

*surgical management

Page 5: THORACIC AORTIC PATHOLOGY CHALLENGES AND SOLUTIONS Thomas C. Naslund, M.D. Vanderbilt University Medical Center.
Page 6: THORACIC AORTIC PATHOLOGY CHALLENGES AND SOLUTIONS Thomas C. Naslund, M.D. Vanderbilt University Medical Center.

PENETRATING ULCER

Page 7: THORACIC AORTIC PATHOLOGY CHALLENGES AND SOLUTIONS Thomas C. Naslund, M.D. Vanderbilt University Medical Center.

INTRAMURAL HEMATOMA

Page 8: THORACIC AORTIC PATHOLOGY CHALLENGES AND SOLUTIONS Thomas C. Naslund, M.D. Vanderbilt University Medical Center.

THORACIC AORTIC ANEURYSM

• Atherosclerosis of iliacs– 8-9 mm EI make most TEVAR easy

– 7-8 mm EI make some TEVAR difficult

– <6 mm EI is a clear danger zone (alternate access)• Dilation with serial dilators if EI normal

• KY jelly helps

• Extreme caution with dilators and atherosclerosis

• Tortuosity of iliacs and TA (arch)• Neck

– <2cm in straight distal attachment can work

– 2cm with angle in arch will not work

Page 9: THORACIC AORTIC PATHOLOGY CHALLENGES AND SOLUTIONS Thomas C. Naslund, M.D. Vanderbilt University Medical Center.

ACCESS FOR THE DISEASED ILIAC

• Conduit– Sutured to the CI artery end to side– Complete TEVAR via conduit– Consider anastomosis to CFA after completion

• May need secondary intervention• CFA may already be exposed/opened/damaged

• Direct CI/Abdominal Aorta Access– Transverse incision over rectus sheath– Retract rectus laterally/RP dissection– CI/terminal aorta easily exposed – Counter puncture in lower quadrant– Direct arterial closure

Page 10: THORACIC AORTIC PATHOLOGY CHALLENGES AND SOLUTIONS Thomas C. Naslund, M.D. Vanderbilt University Medical Center.

GOALS OF ENDOVASCULAR MANAGEMENT

Acute Type B Aortic Dissection

• Redirect flow into true lumen

• Cover entire descending thoracic aorta

• Provide satisfactory visceral flow

• Facilitate aortic healing

• Avoid surgical repair

Page 11: THORACIC AORTIC PATHOLOGY CHALLENGES AND SOLUTIONS Thomas C. Naslund, M.D. Vanderbilt University Medical Center.

DISSECTION TREATMENT ALGORITHM

• Type A- Medical Therapy &Emergency Cardiac Surgery Evaluation

• Type B- Medical therapy» Stent graft for complications in acute phase» Stent graft for aneurysm formation in late follow up» Long term follow up for all Type B to assess aneurysm

formation/stent graft

Page 12: THORACIC AORTIC PATHOLOGY CHALLENGES AND SOLUTIONS Thomas C. Naslund, M.D. Vanderbilt University Medical Center.

NECK PROBLEMS/SOLUTIONS

• Big (>36mm) – 45mm TAG in EU

• Small (<23mm)– 18-23mm diameter graft

• Short (< 2cm)– Debranching/fenestration

• Angled (>?)– Specific design/fenestration

Page 13: THORACIC AORTIC PATHOLOGY CHALLENGES AND SOLUTIONS Thomas C. Naslund, M.D. Vanderbilt University Medical Center.

LENGTHENING THE NECKCovering Branch Vessels

• Left Subclavian– Consider vertebrobasilar circulation

• Contralateral vertebral/carotid disease

• Celiac– Consider pancreaticoduodenal and gastroduodenal

• SMA disease

• Coiling typically not needed– Subclavian for Type II leak

• Transbrachial– Celiac

• Flow robust– Catheterize, cover celiac/trap catheter, coil

Page 14: THORACIC AORTIC PATHOLOGY CHALLENGES AND SOLUTIONS Thomas C. Naslund, M.D. Vanderbilt University Medical Center.
Page 15: THORACIC AORTIC PATHOLOGY CHALLENGES AND SOLUTIONS Thomas C. Naslund, M.D. Vanderbilt University Medical Center.

SURGICAL DEBRANCHING

• Viscerals– Celiotomy

• Midline gets all 4

• Left flank gets 3,maybe 4

• Arch– Left subclavian to carotid transposition– Carotid-carotid bypass (retroesophageal)– Aortoinnominant & carotid bypass

Page 16: THORACIC AORTIC PATHOLOGY CHALLENGES AND SOLUTIONS Thomas C. Naslund, M.D. Vanderbilt University Medical Center.
Page 17: THORACIC AORTIC PATHOLOGY CHALLENGES AND SOLUTIONS Thomas C. Naslund, M.D. Vanderbilt University Medical Center.

ARCH REPAIR

Page 18: THORACIC AORTIC PATHOLOGY CHALLENGES AND SOLUTIONS Thomas C. Naslund, M.D. Vanderbilt University Medical Center.

TRAUMATIC TRANSECTION

• Deceleration injury–MVA

–falls

• Sudden movement of aortic arch

• Circumferential tear of arterial intima and media

• Survivors have intact adventitia and possibly some media

Page 19: THORACIC AORTIC PATHOLOGY CHALLENGES AND SOLUTIONS Thomas C. Naslund, M.D. Vanderbilt University Medical Center.

TRAUMATIC TRANSECTION

• Innominate artery second most common site

Page 20: THORACIC AORTIC PATHOLOGY CHALLENGES AND SOLUTIONS Thomas C. Naslund, M.D. Vanderbilt University Medical Center.

VANDERBILT SERIESOpen Repair 1987

• 41 Patients

• 5 Died without repair– 3 preoperatively

– 2 en route with emergency thoracotomy

• 5/36 Repaired died during operation– 3/5 associated with aortic clamping

• 2/36 Paraparesis

Page 21: THORACIC AORTIC PATHOLOGY CHALLENGES AND SOLUTIONS Thomas C. Naslund, M.D. Vanderbilt University Medical Center.

TRANSECTION PRE OP MEDICAL MANAGEMENT

• Beta Blockade

• BP/HR control

• Discontinue after repair

Page 22: THORACIC AORTIC PATHOLOGY CHALLENGES AND SOLUTIONS Thomas C. Naslund, M.D. Vanderbilt University Medical Center.

STENT GRAFT REPAIR OF TRAUMATIC TRANSECTION

n = 20

• Since 2005

• Age 35 (15 – 72)

• Mortality 1/20 (5%) – 72 yo MSOF

Page 23: THORACIC AORTIC PATHOLOGY CHALLENGES AND SOLUTIONS Thomas C. Naslund, M.D. Vanderbilt University Medical Center.

STENT GRAFT REPAIR OF TRAUMATIC TRANSECTION

n = 20• Mean procedure time 103min

• Mean blood loss 390ml

• Mean intraoperative transfusion 1 unit

• Grafts utilized– TAG - 9

– Cook Iliac extenders- 9

– Excluder aortic cuffs - 2

Page 24: THORACIC AORTIC PATHOLOGY CHALLENGES AND SOLUTIONS Thomas C. Naslund, M.D. Vanderbilt University Medical Center.

STENT GRAFT REPAIR OF TRAUMATIC TRANSECTION

n = 20

• Technical success 100%– graft exclusion of injured

segment

– No deaths pre operatively

• Operative complications– groin access site – 2

– TAG graft collapse – 2

– spinal cord injury – 0

– dialysis – 0

Page 25: THORACIC AORTIC PATHOLOGY CHALLENGES AND SOLUTIONS Thomas C. Naslund, M.D. Vanderbilt University Medical Center.

LATE FOLLOW UP

• Erosions – 0

• Endoleaks/aneurysm – 0

• Access site false aneurysm – 0

• Paraplegia – 0

• Secondary interventions – 0

Page 26: THORACIC AORTIC PATHOLOGY CHALLENGES AND SOLUTIONS Thomas C. Naslund, M.D. Vanderbilt University Medical Center.

USE OF COOK ILIAC LIMB EXTENDER

• Aorta diameter too small for TAG prosthesis (<23mm)

• 55 mm length (satisfactorily covers entire area of injury)

• Z stent design (no collapse)

• Requires manual loading into long sheath to reach aortic arch

Page 27: THORACIC AORTIC PATHOLOGY CHALLENGES AND SOLUTIONS Thomas C. Naslund, M.D. Vanderbilt University Medical Center.
Page 28: THORACIC AORTIC PATHOLOGY CHALLENGES AND SOLUTIONS Thomas C. Naslund, M.D. Vanderbilt University Medical Center.

ZENITH Delivery and Deployment

Page 29: THORACIC AORTIC PATHOLOGY CHALLENGES AND SOLUTIONS Thomas C. Naslund, M.D. Vanderbilt University Medical Center.
Page 30: THORACIC AORTIC PATHOLOGY CHALLENGES AND SOLUTIONS Thomas C. Naslund, M.D. Vanderbilt University Medical Center.

USE OF ABDOMINAL AORTIC CUFF EXTENDERS

• 33 – 36 mm length

• Reported in several series with success

• Requires 3 or more individual cuffs to bridge injured region

• Requires inventory of substantial numbers of aortic cuffs

• Cook, Medtronic, and Gore

Page 31: THORACIC AORTIC PATHOLOGY CHALLENGES AND SOLUTIONS Thomas C. Naslund, M.D. Vanderbilt University Medical Center.

TIGHT ARCH

• Typical of adolescence and young adults

• Implant can either poorly oppose the inner arch and collapse

Page 32: THORACIC AORTIC PATHOLOGY CHALLENGES AND SOLUTIONS Thomas C. Naslund, M.D. Vanderbilt University Medical Center.
Page 33: THORACIC AORTIC PATHOLOGY CHALLENGES AND SOLUTIONS Thomas C. Naslund, M.D. Vanderbilt University Medical Center.

FOLLOW UP

• Interval CT in 1 – 3 days (renal function considerations)

• Follow up CT 1 -3 months after discharge

• Annual CT • Eventually CT each 3-5

years • Emphasis on permanent

life-long follow up

Page 34: THORACIC AORTIC PATHOLOGY CHALLENGES AND SOLUTIONS Thomas C. Naslund, M.D. Vanderbilt University Medical Center.

LATE CONCERNS

• Erosion

• False aneurysm formation

• Infections

Page 35: THORACIC AORTIC PATHOLOGY CHALLENGES AND SOLUTIONS Thomas C. Naslund, M.D. Vanderbilt University Medical Center.

MINIMAL AORTIC INJURY

• Focal-non-circumferential intimal disruption

• No false aneurysm

• No periaortic hematoma

• Suitable for medical therapy and CT follow up rather than intervention– Healing typical in 3-6 months– Persistent fixed lesions identified after 1 year

followup


Recommended